Ftse Mib
34.160,97
1,25%
DAX
19.984,32
0,74%
S&P 500
5.970,84
-1,11%
NASDAQ
19.722,03
-1,49%
Bitcoin
94.457,35
0,31%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Pliant Therapeutics Inc (PLRX) Pliant Therapeutics Inc (PLRX) Notizie

Pliant Therapeutics Inc

PLRX
13,56
-0,47 (-3,35%)
28 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
21/11/202414:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
19/11/202400:00GLOBEPliant Therapeutics Presents Data from its Bexotegrast..
14/11/202423:05EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
07/11/202422:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202422:14EDGAR2Form 8-K - Current report
07/11/202422:05GLOBEPliant Therapeutics Provides Corporate Update and Reports..
06/11/202414:00GLOBEPliant Therapeutics to Participate in the Stifel Healthcare..
17/10/202414:00GLOBEPliant Therapeutics INTEGRIS-PSC Phase 2a Data Evaluating..
04/10/202423:34EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
01/10/202422:35GLOBEPliant Therapeutics Appoints Gary Palmer, M.D. as Senior..
30/9/202422:45GLOBEPliant Therapeutics Announces Inducement Grant Under Nasdaq..
27/9/202422:11EDGAR2Form 8-K - Current report
24/9/202414:00GLOBEAligos Therapeutics Strengthens Senior Leadership Team with..
10/9/202414:00GLOBEPliant Therapeutics Presents Data from its Bexotegrast..
28/8/202414:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
26/8/202415:10GLOBEPliant Therapeutics Announces Four Upcoming Presentations at..
07/8/202422:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202422:08EDGAR2Form 8-K - Current report
07/8/202422:05GLOBEPliant Therapeutics Provides Corporate Update and Reports..
06/8/202422:03GLOBEPliant Therapeutics to Participate in the Canaccord Genuity..
15/7/202417:54EDGAR2Form 8-K - Current report
15/7/202414:00GLOBEPliant Therapeutics Announces Positive Long-Term Data from..
13/7/202400:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/7/202400:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/7/202400:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/7/202422:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/7/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/7/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202402:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202402:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202422:04EDGAR2Form 8-K - Current report
13/6/202422:05GLOBEPliant Therapeutics Announces Appointment of Steve Krognes..
12/6/202422:05GLOBEPliant Therapeutics Announces Inducement Grant Under Nasdaq..
06/6/202414:00GLOBEPliant Therapeutics Presents Data from its Bexotegrast..
22/5/202400:50GLOBEPliant Therapeutics Presents Data from its Bexotegrast..
14/5/202413:43EDGAR2Form 8-K - Current report
14/5/202413:30GLOBEPliant Therapeutics Announces Positive Topline Data from a..
07/5/202414:00GLOBEPliant Therapeutics Announces Upcoming Presentations at the..
06/5/202422:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/5/202422:11EDGAR2Form 8-K - Current report
06/5/202422:05GLOBEPliant Therapeutics Provides Corporate Update and Reports..
06/5/202412:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/5/202414:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
02/4/202414:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
27/3/202415:23GLOBEPliant Therapeutics Announces Upcoming Presentations at the..
12/3/202412:30GLOBEPliant Therapeutics Announces Accelerated Bexotegrast..
27/2/202422:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/2/202422:06EDGAR2Form 8-K - Current report
27/2/202422:03GLOBEPliant Therapeutics Provides Corporate Update and Reports..
26/2/202414:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
Apertura: 14,02 Min: 13,48 Max: 14,23
Chiusura: 14,03

La tua Cronologia

NASDAQ
PLRX
Pliant Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network